
Optimizing Cardiovascular Health: Risk Assessment and Guideline-Driven Hyperlipidemia Interventions

Optimizing Cardiovascular Health: Risk Assessment and Guideline-Driven Hyperlipidemia Interventions is organized by Prime Education, LLC.
Release Date: September 15, 2023
Expiration Date: September 14, 2024
Description:
Hyperlipidemia stands as the predominant risk factor in the development of cardiovascular disease. Risk assessment is crucial for identifying individuals at risk for cardiovascular disease, allowing for timely interventions to prevent health complications.
This clinical case challenge will guide you through a real-world scenario while testing your ability to assess cardiovascular risk and apply the latest clinical evidence for the treatment of hyperlipidemia.
This activity is delivered in partnership with The American Society for Preventive Cardiology.
Learning Objectives:
• Evaluate the latest clinical data on the safety and efficacy of current and emerging lipid-lowering treatments
• Integrate the latest knowledge and evidence about lipid-lowering strategies and ASCVD risk assessment into treatment decision-making for patients with hyperlipidemia
• Apply current guidelines and clinical evidence, along with Merit-Based Incentive Payment System (MIPS) programs, to guide treatment and management to support patients with hyperlipidemia in reaching recommended LDL-C goals to optimize health outcomes